Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX – Get Free Report) declared a dividend on Monday, July 13th. Stockholders of record on Thursday, July 23rd will be given a dividend of 1.50 per share by the specialty pharmaceutical company on Friday, July 31st. The ex-dividend date of this dividend is Thursday, July 23rd.
Cumberland Pharmaceuticals Stock Up 10.3%
CPIX stock opened at $6.54 on Tuesday. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.95 and a quick ratio of 0.79. The stock has a market capitalization of $97.97 million, a P/E ratio of -13.35 and a beta of 0.09. Cumberland Pharmaceuticals has a fifty-two week low of $1.85 and a fifty-two week high of $7.36. The business has a 50-day moving average of $5.70 and a 200-day moving average of $4.45.
Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) last announced its earnings results on Tuesday, May 5th. The specialty pharmaceutical company reported ($0.13) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.13). Cumberland Pharmaceuticals had a negative return on equity of 12.01% and a negative net margin of 17.60%.The business had revenue of $9.13 million for the quarter, compared to analyst estimates of $8.50 million.
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc (NASDAQ:CPIX) is a specialty pharmaceutical company based in Nashville, Tennessee, focused on the development, manufacture and commercialization of hospital and acute care products. Founded in 1993, the company has built a portfolio of branded therapeutics designed to address critical care needs in emergency medicine, critical care units and other hospital settings. Cumberland’s strategy emphasizes in-licensing and acquiring products that have established safety and efficacy profiles but limited market reach, then leveraging its sales network to expand their commercial footprint.
The company’s flagship products include Acetadote (N-acetylcysteine injection), the only FDA-approved antidote for acetaminophen overdose administered intravenously; Vasostrict (vasopressin injection), used to raise blood pressure in adults with vasodilatory shock; Cerebrex (diclofenac sodium injection), an anti-inflammatory agent for managing acute pain and fever; and Dynastat (parecoxib sodium), a COX-2 inhibitor for postoperative pain relief.
Further Reading
- Five stocks we like better than Cumberland Pharmaceuticals
- Fission for Profits: Unlocking America’s Uranium Vault
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
